Zacks.com on MSN1h
HSIC Stock Might Rise Following the Acquisition of Acentus
Henry Schein, Inc. HSIC recently completed the acquisition of substantially all of the assets of Acentus, a national medical ...
CSR upped to Buy as Janney adds stock to 2025 REIT honorable mentions list
Janney on Monday upgraded Centerpspace ( NYSE: CSR) stock to Buy from Neutral and added it to its REIT honorable mentions ...
Hershey’s Sell Rating: Rising Costs and Strategic Challenges Ahead
Analyst Thomas Palmer of Citi maintained a Sell rating on The Hershey Company (HSY – Research Report), retaining the price target of ...
DBS Sticks to Its Buy Rating for Hysan Development Co (HYSNF)
In a report released yesterday, Percy Leung from DBS maintained a Buy rating on Hysan Development Co (HYSNF – Research Report), with a price ...
Pfizer Sells 700 Million Haleon Shares for $3.05 Billion
The sale decreases Pfizer’s shareholding in the consumer-healthcare business to 7.3% of its issued share capital, down from ...
Hims & Hers Stock Is Poised for a Major Surge in 2025
Hims & Hers (NYSE: HIMS) has been on a wild journey over the past year as GLP-1s drive both big gains and big losses for the ...